Skip to main content
SpringerLink
Log in

Wichtige Differenzialdiagnose bei akut einsetzenden Cephalgien

Das reversible zerebrale Vasokonstriktionssyndrom

  • zertifizierte fortbildung
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

Zusammenfassung

Das reversible zerebrale Vasokonstriktionssyndrom (RCVS) ist eine Erkrankung, welche unter anderem durch rezidivierende Attacken eines Donnerschlagkopfschmerzes, mögliche Schlaganfälle sowie multisegmentale Vasospasmen in den zerebralen Arterien gekennzeichnet ist. Für die Diagnose ist unter anderem der Nachweis der Reversibilität der zerebralen Vasokonstriktionen innerhalb von drei Monaten notwendig, welcher durch CT- oder MRT-Angiografien oder transkranielle farbkodierte Duplexsonografie (TCCD) erfolgen kann.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
3

Literatur

  1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

    Article  Google Scholar 

  2. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007;146:34–44.

    Article  Google Scholar 

  3. Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency. Ther Adv Neurol Disord 2010;3:161–171.

    Article  Google Scholar 

  4. Fisher CM. Cerebral ischemia — less familiar types. Clin Neurosurg 1971;18:267–336.

    Article  CAS  Google Scholar 

  5. Call GK, Fleming MC, Sealfon S, Leviine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke 1988;19:1159–1970.

    Article  CAS  Google Scholar 

  6. Dodick DW, Brown RD Jr., Britton JW, Huston J. Nonaneurysnal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalagia 1999;19:118–123.

    Article  CAS  Google Scholar 

  7. Calabrese LH, Gragg LA, Furlan AJ. Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol 1993;20:2046–2050.

    CAS  PubMed  Google Scholar 

  8. Bogousslavsky J, Despland PA, Regli F, Dubuis PY. Postpartum cerebral angiopathy: reversible vasoconstriction assessed by transcranial Doppler ultrasounds. Eur Neurol 1989;29:102–105.

    Article  CAS  Google Scholar 

  9. Jackson M, Lennox G, Jaspan T, Jefferson D. Migraine angiitis precipitated by sex headache and leading to watershed infarction. Cephalalgia 1993;13:427–430.

    Article  CAS  Google Scholar 

  10. Raroque HG Jr, Tesfa G, Purdy P. Postpartum cerebral angiopathy. Is there a role for sympathomimetic drugs? Stroke 1993;24:2108–2110.

    Article  Google Scholar 

  11. Razavi M, Bendixen B, Maley JE, et al. CNS pseudovasculitis in a patient with pheochromocytoma. Neurology 1999;52:1088–1090.

    Article  CAS  Google Scholar 

  12. Solomon S, Lipton RB, Harris PY. Arterial stenosis in migraine: spasm or arteriopathy? Headache 1990;30:52–61.

    Article  CAS  Google Scholar 

  13. Ducros A. Reversible cerebral vasoconstriction syndrome. Handb Clin Neurol 2014;121:1725–1741.

    Article  Google Scholar 

  14. Kirton A, Diggle J, Hu W, Wirrell E. A pediatric case of reversible segmental cerebral vasoconstriction. Can J Neurol Sci 2006;33:250–253.

    Article  Google Scholar 

  15. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007;130:3091–3101.

    Article  Google Scholar 

  16. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906–917.

    Article  Google Scholar 

  17. Fugate JE, Ameriso SF, Ortiz G, Schottlaender LV, Wijdicks EFM, Flemming KD, Rabinstein AA. Variable presentations of postpartum angiopathy. Stroke 2012;43:670–676.

    Article  Google Scholar 

  18. Modi M, Modi G. Postpartum cerebral angiopathy in a patient with chronic migraine with aura. Headache 2000;40:677–681.

    Article  CAS  Google Scholar 

  19. Müller R, Meier O, Haberl RL. Reversible cerebral vasoconstriction syndrome after preeclampsia. Perspectives in Medicine 2012;1:443–445.

    Article  Google Scholar 

  20. Janssens E, Ommel M, Mounier-Vehier F, Leclerc X, Guerin du Masgenet B, Leys D. Postpartum cerebral angiopathy possibly due to bromocriptrine therapy. Stroke 1995;26:128–130.

    Article  CAS  Google Scholar 

  21. Henry PY, Larre P, Aupy M, Lafforgue JL, Orgogozo JM. Reversible cerebral arteriopathy associated with the administration of ergot derivates. Cephalalgia 1984;4(3):171–178.

    Article  CAS  Google Scholar 

  22. John S, Donnelly M, Uchino K. Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome. Headache 2013;53:1482–1487.

    PubMed  Google Scholar 

  23. Wardrope KE, Manson L, Metcalfe W, Sullivan ED. Acute respiratory distress syndrome and posterior reversible encephalopathy syndrome following rituximab therapy. Case rep Nephrol Dial 2016;24:32–39.

    Article  Google Scholar 

  24. Martin K, Rogers T, Kavanaugh A. central nervous system angiopathy associated with cocaine abuse. J rheumatol 1995;22:780–782.

    CAS  PubMed  Google Scholar 

  25. Mateo I, Pinedo A, Gomez-Beldarrain M, Basterretxea JM, Garcia-Monco JC. Recurrent stroke associated with cannabis use. J Neurol Neurosurg Psychiatry 2005;76:435–437.

    Article  CAS  Google Scholar 

  26. Calic Z, Choong H, Schlaphoff G, Cappelen-Smith C. Reversible cerebral vasoconstriction following indomethacin. Cephalalgia 2014;34:1181–1186.

    Article  Google Scholar 

  27. Loewen AH, Hudon ME, Hill MD. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. CMAJ 2004;171:593–594.

    Article  Google Scholar 

  28. Soo Y, Singhal AB, Leung T, Yu S, Mak H, Hao Q, Leung H, Lam W, Wong LK. Reversible cerebral vasoconstriction syndrome with posterior leucoencephalopathy after oral contraceptive pills. Cephalalgia 2010;30:42–45.

    Article  CAS  Google Scholar 

  29. Wolff V, Ducros A. Reversible cerebral vasoconstriction syndrome without typical thunderclap headache. Headache 2016;4:674–687.

    Article  Google Scholar 

  30. Walsh RD, Floyd JP, Eidelman BH, Barrett KM. Balint syndrome and visual allochiria in a patient with reversible cerebral vasoconstriction syndrome. J Neuroophthalmol 2012;32:302–306.

    Article  Google Scholar 

  31. Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term follow-up. Arthritis Rheum 2002;47:662–669.

    Article  Google Scholar 

  32. Singhal AB, Ducros A. Reversible cerebral vasoconstriction syndromes.In: Mohr JP, Wolf PA, Grotta JC, Moskowitz MA, Mayberg MR, Kumar VR, eds. Stroke (Fifth edn.). Saint Louis: W.B.Saunders 2011;765–771.

    Chapter  Google Scholar 

  33. Chen SP, Wang YF, Huang PH, Chi CW, Fuh JL, Wang SJ. Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome. J headache pain 2014;15:82–88.

    Article  CAS  Google Scholar 

  34. Liman TG, Bachelier-Walenta K, Neeb L, et al. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia 2015;35:88–94.

    Article  Google Scholar 

  35. Salem M, Kamal S, El Sherbiny W, Abdel Aal AA. Flow cytometric assessment of endothelial and platelet microparticles in preeclampsia and their relation to disease severity and Doppler parameters. Hematology 2015;20:154–159.

    Article  Google Scholar 

  36. Chen SP, Fuh JL, Wang SJ, Tsai SJ, Hong CJ, Yang AC. Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS One 2011;18:18024–18029.

    Article  Google Scholar 

  37. Singhal AB, Hajj-Ali R, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH. Reversible cerebral vasoconstriction syndromes. Analysis of 139 cases. Arch Neurol 2011;68:1005–1012.

    Article  Google Scholar 

  38. Ghia D, Cuganesan R, Cappelen-Smith C. Delayed angiographic changes in postpartum cerebral angiography. J Clin Neurosci 2011;18:435–436.

    Article  Google Scholar 

  39. Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ. Transcranial color doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 2008;63:751–757.

    Article  Google Scholar 

  40. Kubo S, Nakata H, Tatsumi T, Yoshimine T. Headache associated with postpartum angiopathy: Monitoring with transcranial color-codes sonography. Hedache 2002;42:297–300.

    Article  Google Scholar 

  41. Sixt GJ, Diener HC. Thunderclap headache. Aktuelle Neurologie 2003;30:1–7.

    Article  Google Scholar 

  42. Krämer M, Berlit P. Reversibles zerebrales Vasokonstriktionssyndrom vs. zerebrale Vaskulitis. Nervenarzt 2011;82:500–505.

    Article  Google Scholar 

  43. Lamy C, Oppenheim C, Mas JL. Posterior reversible encephalopathy syndrome. Handb Clin Neurol 2014;121:1687–1701.

    Article  CAS  Google Scholar 

  44. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leucoencephalopathy syndrome. Arch neurol 2008;65:205–210.

    PubMed  Google Scholar 

  45. Staykov D, Schwab S. Posterior reversible encephalopathy syndrome. J Intensive Care med 2012;27:11–24.

    Article  Google Scholar 

  46. Bayer-Karpinska A, Patzig M, Adamczyk C et al. Reversible cerebral vasoconstriction syndrome with concurrent bilateral carotid artery dissection. Cephalalgia 2013;33:491–495.

    Article  Google Scholar 

  47. McKinney JS, Messé SR, Pukenas BA, Satti SR, Weigele JB, Hurst RW, Levine JM, Kasner SE, Sansing LH. Intracranial vertebrobasilar artery dissection associated with postpartum angiopathy. Stroke Res Treat. 2010; Article ID 320627,5 pages.

  48. Mitchell LA, Santarelli JG, Singh IP, Do HM, et al. Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after caesarean section. J Neurointerv Surg 2014;6:5–8.

    Article  Google Scholar 

  49. Nouh A, Ruland S, Schneck MJ, Pasquale D, Biller J. Reversible cerebral vasoconstriction syndrome with multivessel cervical artery dissections and a double aortic arch. J Stroke Cerebrovasc Dis. 2014;23:e141–e143.

    Article  Google Scholar 

  50. Mawet J, Debette S, Bousser MG, Ducros A. The link between migraine, reversible cerebral vasoconstriction syndrome and cervical artery dissection. Headache 2016;56:645–656.

    Article  Google Scholar 

  51. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009;8:668–678.

    Article  Google Scholar 

  52. Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ. Nimodipine for treatment of primary thunderclap headache. Neurology 2004;62:1414–1416.

    Article  CAS  Google Scholar 

  53. Singhal AB. Postpartum angiopathy with reversible posterior leucoencephalopathy. Arch Neurol 2004;61:411–416.

    Article  Google Scholar 

  54. Farid H, Tatum JK, Wong C, Halbach VV, Hetts SW. Reversible cerebral vasoconstriction syndrome treatment with combined intra-arterial verapamil infusion and intracranial angioplasty. Am J Neuroradiol 2011;32:E184–187.

    Article  CAS  Google Scholar 

  55. Ioannidis I, Nasis Nm Agianniotaki A, katsouda E, Andreou A. Reversible cerebral vasoconstriction syndrome: treatment with multiple sessions of intra-arterial nimodipine and angioplasty. Interv Neuroradiol 2012;18:297–302.

    Article  CAS  Google Scholar 

  56. Linn J, Fesl G, Ottomeyer C, Straube A, Dichgans M, Bruckmann H, Pfefferkorn T. Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia 2011;31:1074–1081.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Neurologie, Krankenhaus Bozen, Lorenz Böhler Straße 5, 39100, Bozen, Italien

    Gabriele Johanna Sixt,  Susanne Büchner &  Monika Wallnöfer

  2. Abteilung für Innere Medizin, Krankenhaus Bozen, Bozen, Italien

    Giuseppe Roscia

Authors
  1. Gabriele Johanna Sixt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susanne Büchner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monika Wallnöfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Roscia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriele Johanna Sixt.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen haben leiten lassen und im Zusammenhang mit diesem Beitrag keine Interessenkonflikte bestehen.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.

Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sixt, G.J., Büchner, S., Wallnöfer, M. et al. Das reversible zerebrale Vasokonstriktionssyndrom. InFo Neurologie 20, 30–38 (2018). https://doi.org/10.1007/s15005-018-2367-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-018-2367-6

Search

Navigation